These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4369295)

  • 1. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression, and interferon synthesis in human lymphoblastoid cell lines.
    Joncas J; Boucher J; Boudreault A; Granger-Julien M
    Cancer Res; 1973 Sep; 33(9):2142-8. PubMed ID: 4353485
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):78-82. PubMed ID: 4550511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids.
    Magrath IT; Pizzo PA; Novikovs L; Levine AS
    Virology; 1979 Sep; 97(2):477-81. PubMed ID: 224594
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 7. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine.
    Gerber P; Lucas S
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):431-8. PubMed ID: 4344263
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
    Rocchi G; Hewetson J; Henle W; Henle G
    J Natl Cancer Inst; 1973 Feb; 50(2):307-14. PubMed ID: 4349762
    [No Abstract]   [Full Text] [Related]  

  • 10. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Epstein-Barr virus-related membrane antigens by 5-iododeoxyuridine in non-producer human lymphoblastoid cells.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1973 Nov; 246(151):70-2. PubMed ID: 4357308
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-exposure of human lymphoblastoid cell lines to Epstein-Barr virus.
    Diehl V; Wolf H; Schulte-Holthausen H; zur Hausen H
    Int J Cancer; 1972 Nov; 10(3):641-51. PubMed ID: 4358042
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
    Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
    J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A; Friedrichs C; Thust R; Wutzler P
    Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid.
    Thorley-Lawson D; Strominger JL
    Nature; 1976 Sep; 263(5575):332-4. PubMed ID: 183149
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.